Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 8,390 Shares of Stock
Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 8,390 shares of the firm’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $116.47, for a total transaction of $977,183.30. Following the completion of the sale, the executive vice president now owns 35,052 shares in the company, valued at $4,082,506.44. The sale was disclosed in a document filed with the SEC, which is available at this link.
Shares of Varian Medical Systems, Inc. (NYSE:VAR) traded down $0.46 during trading hours on Tuesday, reaching $116.24. 628,520 shares of the company traded hands, compared to its average volume of 977,594. Varian Medical Systems, Inc. has a 12-month low of $79.86 and a 12-month high of $130.29. The firm has a market cap of $10,453.88, a price-to-earnings ratio of 92.99, a P/E/G ratio of 3.32 and a beta of 0.81.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The company had revenue of $678.50 million for the quarter, compared to the consensus estimate of $633.96 million. During the same period last year, the firm posted $1.09 EPS. Varian Medical Systems’s revenue for the quarter was up 12.8% on a year-over-year basis. analysts anticipate that Varian Medical Systems, Inc. will post 4.31 EPS for the current fiscal year.
Several equities research analysts recently commented on VAR shares. Zacks Investment Research lowered shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Citigroup lifted their price target on shares of Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research note on Monday, October 30th. Evercore ISI started coverage on shares of Varian Medical Systems in a research note on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price target on the stock. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, October 29th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Varian Medical Systems from $88.00 to $105.00 and gave the stock a “neutral” rating in a research note on Thursday, January 25th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $108.44.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.